# Reducing Non-Alcoholic Steatohepatitis

> **NCT06519448** · NA · ENROLLING_BY_INVITATION · sponsor: **Military University Hospital, Prague** · enrollment: 30 (estimated)

## Conditions studied

- Non-alcoholic Steatohepatitis
- Liver Diseases
- Diabetes Mellitus, Type 2
- Fibrosis, Liver

## Interventions

- **DRUG:** Empagliflozin 10 miligrams (mg)

## Key facts

- **NCT ID:** NCT06519448
- **Lead sponsor:** Military University Hospital, Prague
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06519448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06519448, "Reducing Non-Alcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06519448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*